Dnaprint Genomics Stock Technical Analysis
DNAPrint Genomics technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices.
DNAPrint Genomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as DNAPrint, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DNAPrintDNAPrint Genomics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Can Biotechnology industry sustain growth momentum? Does DNAPrint have expansion opportunities? Factors like these will boost the valuation of DNAPrint Genomics. Projected growth potential of DNAPrint fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating DNAPrint Genomics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between DNAPrint Genomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DNAPrint Genomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, DNAPrint Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
DNAPrint Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DNAPrint Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DNAPrint Genomics.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in DNAPrint Genomics on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding DNAPrint Genomics or generate 0.0% return on investment in DNAPrint Genomics over 90 days. DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services More
DNAPrint Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DNAPrint Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DNAPrint Genomics upside and downside potential and time the market with a certain degree of confidence.
DNAPrint Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNAPrint Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DNAPrint Genomics' standard deviation. In reality, there are many statistical measures that can use DNAPrint Genomics historical prices to predict the future DNAPrint Genomics' volatility.DNAPrint Genomics Backtested Returns
We have found zero technical indicators for DNAPrint Genomics, which you can use to evaluate the volatility of the firm. The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DNAPrint Genomics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
DNAPrint Genomics has no correlation between past and present. Overlapping area represents the amount of predictability between DNAPrint Genomics time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DNAPrint Genomics price movement. The serial correlation of 0.0 indicates that just 0.0% of current DNAPrint Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
DNAPrint Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
DNAPrint Genomics Technical Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of DNAPrint Genomics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About DNAPrint Genomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of DNAPrint Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of DNAPrint Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on DNAPrint Genomics price pattern first instead of the macroeconomic environment surrounding DNAPrint Genomics. By analyzing DNAPrint Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of DNAPrint Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to DNAPrint Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2011 | 2025 (projected) | Payables Turnover | 0.0317 | 0.56 | 0.5 | Days Of Inventory On Hand | 46.91 | 20.96 | 24.11 |
Complementary Tools for DNAPrint Stock analysis
When running DNAPrint Genomics' price analysis, check to measure DNAPrint Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNAPrint Genomics is operating at the current time. Most of DNAPrint Genomics' value examination focuses on studying past and present price action to predict the probability of DNAPrint Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNAPrint Genomics' price. Additionally, you may evaluate how the addition of DNAPrint Genomics to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |